Efficacy and Safety of Introduction Timolol Maleate by Manometer Microneedles among Infantile Hemangioma: A Retrospective Study in China
Topic overview
This retrospective study of 307 Chinese pediatric patients compares three treatment modalities for infantile hemangioma: timolol maleate via microneedle delivery, topical application, and oral propranolol. Microneedle-assisted timolol demonstrated superior efficacy and cure rates compared to topical application, offering a potentially safer alternative to systemic therapy.
Key takeaways
- Timolol maleate delivered via nano-microneedle showed 92.8% effectiveness and 76.3% cure rate for infantile hemangiomas in 307-patient study.
- Microneedle delivery outperformed topical swab application (group B) in both effectiveness and cure rates for hemangioma treatment.
- Overall adverse reaction rate across all three treatment modalities was low at 9.4%, suggesting good safety profile.
- Study compared three delivery methods: nano-microneedle injection, topical application, and oral propranolol for infantile hemangioma management.
- Intradermal timolol delivery may offer superior local drug penetration compared to surface application in vascular lesion treatment.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Efficacy and Safety of Introduction Timolol Maleate by Manometer Microneedles among Infantile Hemangioma: A Retrospective Study in China. GlobalCastMD Medical Library. 2023-05-01. https://dev.library.globalcastmd.com/article/8448?via_space=staycurrentmd
Comments